Related Experiment Videos
Treatment of a malignant enterocutaneous fistula with octreotide acetate
1Department of Veterans Affairs Medical Center, Washington, DC, USA.
Cancer Investigation
|June 17, 1999
Abstract:
An enterocutaneous malignant fistula developed in a patient who had a retroperitoneal angiosarcoma. He was treated with octreotide acetate subcutaneously. Drainage decreased and ceased after 2 weeks of therapy. The closure of this malignant fistula suggests that palliative therapy with octreotide acetate merits further study in view of the grave prognosis of this complication.